ACA

NEUTRALM&A

Arcosa, Inc.

2026-09-08

Price

$145.65

+0.14%

This is the 2026-09-08 snapshot — the signals and analysis for ACA as of this single trading day.

View full ACA research hub →

Score9.5Priority

Signals6/8 DNA0/13 Act · 0/4 Risk

SentimentNEUTRALScore: 8

Volume1.0xvs 20d avg

Analysis

Arcosa (ACA) is exhibiting textbook merger arbitrage behavior, trading with exceptionally low volatility as it converges toward its $150 all-cash acquisition price from CRH. The recent September 4th stockholder approval removes a critical deal hurdle, perfectly explaining the QUIET_STORM and STEADY_CLIMB technical signals. Furthermore, the current RISK_ON macro regime, highlighted by remarkably tight High Yield OAS spreads (0.81%), confirms that the acquirer faces zero financing friction despite global geopolitical noise. This represents a high-conviction, structural price discovery event with a mathematically defined ceiling.

Fired Signals

ALPHA MALEQUIET STORMSTEADY CLIMBGOLDEN CROSSMARKET LEADERPERFECT STACK

Key Takeaways

Actionable Thesis: ACA is a definitive merger arbitrage play steadily marching toward the $150 cash buyout price following the September 4th shareholder approval.
Key Risk: Regulatory hurdles or unexpected anti-trust roadblocks before the projected early 2027 close are the only tangible threats to the deal.
What to Watch: Monitor the $150 deal price ceiling and any regulatory updates, while relying on the $144.90 support as the arbitrage floor.

← Back to 2026-09-08 View Full ACA History →Yahoo Finance &nearr;